Will Ulta Beauty's FY2026 full-year operating margin exceed 14.0%?

The margin trajectory is 16.1% to 15.0% to 13.9% to guided 12.3-12.4% -- four consecutive years of decline. Going from ~12.3% to >14.0% requires ~170 bps improvement, which would be the first reversal after four years. The committee found SG&A headwinds are structural (Space NK, cloud amortization, loyalty costs). Q3 FY2025 data shows SG&A rose 240 bps even as gross margin improved only 70 bps -- the SG&A problem overwhelms gross margin gains. Three simultaneous international expansions create ongoing cost pressure with no disclosed normalization timeline. The 'recovery at higher cost' finding (E3, 2/2 agreement) directly implies margins don't snap back easily.

The magnitude required is ~170 bps improvement from a declining baseline. The rate of decline is accelerating: 15.0% to 13.9% (110 bps decline), then to 12.3% (160 bps decline). For recovery, Ulta would need to both stabilize gross margin AND meaningfully reduce SG&A as a percentage of revenue. Loyalty costs are escalating (deferred revenue +14.7% vs sales +0.8%), Space NK integration costs have no disclosed end date, and cloud tech amortization is multi-year. Management acknowledged SG&A as 'a key area of focus' but acknowledgment is not execution. Even optimistically, getting above 14% in FY2026 is a stretch given the structural cost ramp.

Data staleness matters -- fundamentals are 397 days old and Q4 FY2025 earnings on March 12, 2026 will provide the most recent baseline. If Q4 FY2025 shows a margin inflection or FY2025 comes in better than guided 12.3-12.4%, the starting point could be higher. However, even if FY2025 ends at 13.0% (unlikely given guidance), reaching >14% still requires 100+ bps improvement against structural headwinds. Three simultaneous international expansions represent a multi-year investment cycle -- companies rarely see margin expansion during international ramp-ups. Committee consensus is clear: moat maintenance costs are rising. Base case is stabilization near 12-13%, not recovery to 14%+.

Four years of margin decline with structural SG&A headwinds identified by the committee. Recovery requires 170+ bps reversal with no evidence it has begun. Management says SG&A is 'a key area of focus' but that's not a plan. The FY2025 guidance of 12.3-12.4% sets a low starting point. Even with March 2026 Analyst Day as a potential catalyst, execution on SG&A optimization typically takes 4-8 quarters to show up in financials. This is a clear NO lean.

The key counterpoint is whether Ulta can leverage revenue growth for SG&A ratio improvement. But the committee specifically found that comp recovery CAME AT THE COST of SG&A deleverage -- meaning growth itself doesn't solve the problem. Three international expansions are incremental costs. Gross margin is improving (+70 bps in Q3), which helps but SG&A headwinds overwhelm. The market at ~26x P/E is pricing in recovery that hasn't started. Even accounting for potential Analyst Day catalyst and positive earnings surprises, the structural cost base makes >14% operating margin in FY2026 unlikely.

Considering upside scenarios: Analyst Day announces aggressive SG&A plan, comps accelerate providing natural operating leverage, or international expansion costs normalize faster than expected. But even optimistically, the math is tough -- SG&A/revenue would need to drop from ~29.4% to ~26-27% territory while maintaining gross margin expansion. That's a massive swing in one fiscal year. More realistic outcome: margin stabilizes in 12.5-13.5% range in FY2026 as management begins optimization but full effects take 2+ years. Assigning slightly higher probability to account for tail upside from Analyst Day catalysts.

Margin declining four straight years. 170+ bps recovery needed from 12.3% baseline. SG&A headwinds are structural per committee (Space NK, cloud amortization, loyalty costs). Committee agrees moat maintenance costs are rising (E3, 2/2). No concrete cost optimization plan disclosed. Clear NO lean.

Starting point of 12.3-12.4% guided for FY2025. Need >14.0% in FY2026 -- a 160-170 bps improvement. Three international expansions adding structural SG&A costs simultaneously. Loyalty deferred revenue growing 14x faster than sales. March 2026 Analyst Day could provide catalyst but execution requires multiple quarters. Long shot.

Gross margin improving (+70 bps in Q3) but SG&A overwhelms (+240 bps deleverage). Recovery at higher cost is the key committee finding -- maintaining competitive position now costs more, compressing economic rent. Analyst Day in March 2026 could serve as catalyst but execution of cost optimization plans typically takes 2+ years to materialize in margins. Base case is margin stabilization, not recovery above 14%.